{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:05:02Z","timestamp":1762625102957},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00393-023-01428-0","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T11:01:48Z","timestamp":1693998108000},"page":"678-687","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Autoinflammatorische Syndrome","Autoinflammatory syndromes"],"prefix":"10.1007","volume":"82","author":[{"given":"Hanna","family":"Bonnekoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Krusche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Feist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette Doris","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Pankow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,6]]},"reference":[{"key":"1428_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","volume":"97","author":"MF McDermott","year":"1999","unstructured":"McDermott\u00a0MF, Aksentijevich\u00a0I, Galon\u00a0J et\u00a0al (1999) Germline mutations in the extracellular domains of the 55\u202fkDa TNF receptor, TNFR1, define a\u00a0family of dominantly inherited autoinflammatory syndromes. Cell 97:133\u2013144","journal-title":"Cell"},{"issue":"7","key":"1428_CR2","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00296-014-3205-x","volume":"35","author":"NA Mukhin","year":"2015","unstructured":"Mukhin\u00a0NA, Kozlovskaya\u00a0LV, Bogdanova\u00a0MV, Rameev\u00a0VV, Moiseev\u00a0SV, Simonyan\u00a0AK (2015) Predictors of AA amyloidosis in familial Mediterranean fever. Rheumatol Int 35(7):1257\u20131261. https:\/\/doi.org\/10.1007\/s00296-014-3205-x","journal-title":"Rheumatol Int"},{"issue":"10","key":"1428_CR3","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/art.24458","volume":"61","author":"E Ben-Chetrit","year":"2009","unstructured":"Ben-Chetrit\u00a0E, Touitou\u00a0I (2009) Familial mediterranean Fever in the world. Arthritis Rheum 61(10):1447\u20131453. https:\/\/doi.org\/10.1002\/art.24458","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1428_CR4","first-page":"31","volume":"1","author":"P Langevitz","year":"1999","unstructured":"Langevitz\u00a0P, Livneh\u00a0A, Padeh\u00a0S et\u00a0al (1999) Familial Mediterranean fever: new aspects and prospects at the end of the millenium. Isr Med Assoc\u00a0J 1(1):31\u201336","journal-title":"Isr Med Assoc J"},{"issue":"3","key":"1428_CR5","doi-asserted-by":"publisher","first-page":"100019","DOI":"10.1016\/j.waojou.2019.100019","volume":"12","author":"M Chuamanochan","year":"2019","unstructured":"Chuamanochan\u00a0M, Weller\u00a0K, Feist\u00a0E et\u00a0al (2019) State of care for patients with systemic autoinflammatory diseases\u2014results of a\u00a0tertiary care survey. World Allergy Organ\u00a0J 12(3):100019. https:\/\/doi.org\/10.1016\/j.waojou.2019.100019","journal-title":"World Allergy Organ J"},{"issue":"7","key":"1428_CR6","doi-asserted-by":"publisher","first-page":"adv00091","DOI":"10.2340\/00015555-3427","volume":"100","author":"H Bonnekoh","year":"2020","unstructured":"Bonnekoh\u00a0H, Butze\u00a0M, Kallinich\u00a0T, Kambe\u00a0N, Kokolakis\u00a0G, Krause\u00a0K (2020) Spectrum of genetic autoinflammatory diseases presenting with cutaneous symptoms. Acta Derm Venereol 100(7):adv91. https:\/\/doi.org\/10.2340\/00015555-3427","journal-title":"Acta Derm Venereol"},{"key":"1428_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00393-017-0265-9","volume":"76","author":"T Kallinich","year":"2017","unstructured":"Kallinich\u00a0T, Orak\u00a0B, Wittkowski\u00a0H (2017) Rolle der Genetik beim famili\u00e4ren Mittelmeerfieber. Z\u00a0Rheumatol 76:303\u2013312. https:\/\/doi.org\/10.1007\/s00393-017-0265-9","journal-title":"Z Rheumatol"},{"issue":"4","key":"1428_CR8","first-page":"568","volume":"26","author":"M Lidar","year":"2008","unstructured":"Lidar\u00a0M, Doron\u00a0A, Kedem\u00a0R, Yosepovich\u00a0A, Langevitz\u00a0P, Livneh\u00a0A (2008) Appendectomy in familial Mediterranean fever: clinical, genetic and pathological findings. Clin Exp Rheumatol 26(4):568\u2013573","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"1428_CR9","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s00108-021-01220-9","volume":"62","author":"A Pankow","year":"2021","unstructured":"Pankow\u00a0A, Feist\u00a0E, Baumann\u00a0U, Kirschstein\u00a0M, Burmester\u00a0GR, Wagner\u00a0AD (2021) What is confirmed in the treatment of autoinflammatory fever diseases? Internist 62(12):1280\u20131289. https:\/\/doi.org\/10.1007\/s00108-021-01220-9","journal-title":"Internist"},{"issue":"16","key":"1428_CR10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","volume":"314","author":"D Zemer","year":"1986","unstructured":"Zemer\u00a0D, Pras\u00a0M, Sohar\u00a0E, Modan\u00a0M, Cabili\u00a0S, Gafni\u00a0J (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N\u00a0Engl J Med 314(16):1001\u20131005. https:\/\/doi.org\/10.1056\/NEJM198604173141601","journal-title":"N Engl J Med"},{"issue":"5","key":"1428_CR11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","volume":"75","author":"C G\u00f6testam Skorpen","year":"2016","unstructured":"G\u00f6testam Skorpen\u00a0C, Hoeltzenbein\u00a0M, Tincani\u00a0A et\u00a0al (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 75(5):795\u2013810. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208840","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1428_CR12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00393-021-01017-z","volume":"80","author":"Z Boyadzhieva","year":"2021","unstructured":"Boyadzhieva\u00a0Z, Ruffer\u00a0N, Krusche\u00a0M (2021) Colchicine: old medication with new benefits : use in rheumatology and beyond. Z\u00a0Rheumatol 80(7):647\u2013657. https:\/\/doi.org\/10.1007\/s00393-021-01017-z","journal-title":"Z Rheumatol"},{"issue":"4","key":"1428_CR13","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","volume":"75","author":"S Ozen","year":"2016","unstructured":"Ozen\u00a0S, Demirkaya\u00a0E, Erer\u00a0B et\u00a0al (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75(4):644\u2013651. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208690","journal-title":"Ann Rheum Dis"},{"issue":"27","key":"1428_CR14","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck\u00a0DB, Ferrada\u00a0MA, Sikora\u00a0KA et al (2020) Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N\u00a0Engl J Med 383(27):2628\u20132638. https:\/\/doi.org\/10.1056\/NEJMoa2026834","journal-title":"N Engl J Med"},{"issue":"1","key":"1428_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/mrcr\/rxab021","volume":"6","author":"F Shaukat","year":"2022","unstructured":"Shaukat\u00a0F, Hart\u00a0M, Burns\u00a0T, Bansal\u00a0P (2022) UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review. Mod Rheumatol Case Rep 6(1):134\u2013139. https:\/\/doi.org\/10.1093\/mrcr\/rxab021","journal-title":"Mod Rheumatol Case Rep"},{"issue":"11","key":"1428_CR16","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jamadermatol.2021.3344","volume":"157","author":"E Zakine","year":"2021","unstructured":"Zakine\u00a0E, Schell\u00a0B, Battistella\u00a0M et\u00a0al (2021) UBA1 variations in neutrophilic dermatosis skin lesions of patients with VEXAS syndrome. JAMA Dermatol 157(11):1349\u20131354. https:\/\/doi.org\/10.1001\/jamadermatol.2021.3344","journal-title":"JAMA Dermatol"},{"issue":"10300","key":"1428_CR17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0140-6736(21)01430-6.","volume":"398","author":"N Dehghan","year":"2021","unstructured":"Dehghan\u00a0N, Marcon\u00a0KM, Sedlic\u00a0T, Beck\u00a0DB, Dutz\u00a0JP, Chen\u00a0LYC (2021) Vacuoles, E1 enzyme, X\u2011linked, autoinflammatory, somatic (VEXAS) syndrome: fevers, myalgia, arthralgia, auricular chondritis, and erythema nodosum. Lancet 398(10300):621. https:\/\/doi.org\/10.1016\/S0140-6736(21)01430-6","journal-title":"Lancet"},{"issue":"10","key":"1428_CR18","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/art.41743","volume":"73","author":"MA Ferrada","year":"2021","unstructured":"Ferrada\u00a0MA, Sikora\u00a0KA, Luo\u00a0Y et\u00a0al (2021) Somatic mutations in UBA1 define a\u00a0distinct subset of relapsing polychondritis patients with VEXAS. Arthritis Rheumatol 73(10):1886\u20131895. https:\/\/doi.org\/10.1002\/art.41743","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"1428_CR19","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/annrheumdis-2021-220089","volume":"80","author":"N Tsuchida","year":"2021","unstructured":"Tsuchida\u00a0N, Kunishita\u00a0Y, Uchiyama\u00a0Y et\u00a0al (2021) Pathogenic. Ann Rheum Dis 80(8):1057\u20131061. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220089","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1428_CR20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/art.41992","volume":"74","author":"F Muratore","year":"2022","unstructured":"Muratore\u00a0F, Marvisi\u00a0C, Castrignan\u00f2\u00a0P et al (2022) VEXAS syndrome: a case series from a\u00a0single-center cohort of Italian patients with Vasculitis. Arthritis Rheumatol 74(4):665\u2013670. https:\/\/doi.org\/10.1002\/art.41992","journal-title":"Arthritis Rheumatol"},{"key":"1428_CR21","doi-asserted-by":"publisher","first-page":"108996","DOI":"10.1016\/j.clim.2022.108996","volume":"238","author":"H Matsumoto","year":"2022","unstructured":"Matsumoto\u00a0H, Asano\u00a0T, Tsuchida\u00a0N et\u00a0al (2022) Beh\u00e7et\u2019s disease with a\u00a0somatic UBA1 variant: expanding spectrum of autoinflammatory phenotypes of VEXAS syndrome. Clin Immunol 238:108996. https:\/\/doi.org\/10.1016\/j.clim.2022.108996","journal-title":"Clin Immunol"},{"issue":"22","key":"1428_CR22","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1056\/NEJMc2102124","volume":"384","author":"DB Beck","year":"2021","unstructured":"Beck\u00a0DB, Grayson\u00a0PC, Kastner\u00a0DL (2021) Mutant UBA1 and severe adult-onset autoinflammatory disease. Reply. N\u00a0Engl J Med 384(22):2164\u20132165. https:\/\/doi.org\/10.1056\/NEJMc2102124","journal-title":"N Engl J Med"},{"issue":"3","key":"1428_CR23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/bjd.20805","volume":"186","author":"S Georgin-Lavialle","year":"2022","unstructured":"Georgin-Lavialle\u00a0S, Terrier\u00a0B, Guedon\u00a0AF et al (2022) Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a\u00a0multicentre case series of 116 French patients. Br J Dermatol 186(3):564\u2013574. https:\/\/doi.org\/10.1111\/bjd.20805","journal-title":"Br J Dermatol"},{"key":"1428_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-022-01169-6","author":"M Zeeck","year":"2022","unstructured":"Zeeck\u00a0M, K\u00f6tter\u00a0I, Krusche\u00a0M (2022) VEXAS syndrome. Z\u00a0Rheumatol. https:\/\/doi.org\/10.1007\/s00393-022-01169-6","journal-title":"Z Rheumatol"},{"issue":"26","key":"1428_CR25","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1182\/blood.2021010811","volume":"137","author":"C Gurnari","year":"2021","unstructured":"Gurnari\u00a0C, Pagliuca\u00a0S, Durkin\u00a0L et\u00a0al (2021) Vacuolization of hematopoietic precursors: an enigma with multiple etiologies. Blood 137(26):3685\u20133689. https:\/\/doi.org\/10.1182\/blood.2021010811","journal-title":"Blood"},{"issue":"22","key":"1428_CR26","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1056\/NEJMc2102124","volume":"384","author":"L Luzzatto","year":"2021","unstructured":"Luzzatto\u00a0L, Risitano\u00a0AM, Notaro\u00a0R (2021) Mutant UBA1 and severe adult-onset autoinflammatory disease. N\u00a0Engl J Med 384(22):2164. https:\/\/doi.org\/10.1056\/NEJMc2102124","journal-title":"N Engl J Med"},{"issue":"8","key":"1428_CR27","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/blood.2022016642","volume":"140","author":"M Heiblig","year":"2022","unstructured":"Heiblig\u00a0M, Ferrada\u00a0MA, Koster\u00a0MJ et\u00a0al (2022) Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a\u00a0retrospective multicenter study. Blood 140(8):927\u2013931. https:\/\/doi.org\/10.1182\/blood.2022016642","journal-title":"Blood"},{"issue":"4","key":"1428_CR28","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/bjh.17893","volume":"196","author":"T Comont","year":"2022","unstructured":"Comont\u00a0T, Heiblig\u00a0M, Rivi\u00e8re\u00a0E et al (2022) Azacitidine for patients with vacuoles, E1 enzyme, X\u2011linked, autoinflammatory, somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry. Br J Haematol 196(4):969\u2013974. https:\/\/doi.org\/10.1111\/bjh.17893","journal-title":"Br J Haematol"},{"issue":"22","key":"1428_CR29","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1056\/NEJMc2102124","volume":"384","author":"A Diarra","year":"2021","unstructured":"Diarra\u00a0A, Duployez\u00a0N, Terriou\u00a0L (2021) Mutant UBA1 and severe adult-onset autoinflammatory disease. N\u00a0Engl J Med 384(22):2163\u20132164. https:\/\/doi.org\/10.1056\/NEJMc2102124","journal-title":"N Engl J Med"},{"key":"1428_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18488","author":"A Al-Hakim","year":"2022","unstructured":"Al-Hakim\u00a0A, Poulter\u00a0JA, Mahmoud\u00a0D et al (2022) Allogeneic haematopoietic stem cell transplantation for VEXAS syndrome: UK experience. Br J Haematol. https:\/\/doi.org\/10.1111\/bjh.18488","journal-title":"Br J Haematol"},{"issue":"5","key":"1428_CR31","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/all.12129","volume":"68","author":"A Simon","year":"2013","unstructured":"Simon\u00a0A, Asli\u00a0B, Braun-Falco\u00a0M et al (2013) Schnitzler\u2019s syndrome: diagnosis, treatment, and follow-up. Allergy 68(5):562\u2013568. https:\/\/doi.org\/10.1111\/all.12129","journal-title":"Allergy"},{"key":"1428_CR32","unstructured":"Schnitzler L (1972) Lesions urticariennes chroniques permanentes (erytheme petaloide?) Cas cliniques. J\u00a0Dermatol Angers 46"},{"key":"1428_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.semarthrit.2007.04.001","volume":"37","author":"HD de Koning","year":"2007","unstructured":"de Koning\u00a0HD, Bodar\u00a0EJ, van der Meer\u00a0JW, Simon\u00a0A (2007) Schnitzler syndrome: beyond the case reports: review and follow-up of 94\u00a0patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 37:137\u2013148","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"1428_CR34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/bjd.15705","volume":"178","author":"H Bonnekoh","year":"2018","unstructured":"Bonnekoh\u00a0H, Scheffel\u00a0J, Maurer\u00a0M, Krause\u00a0K (2018) Use of skin biomarker profiles to distinguish Schnitzler syndrome from chronic spontaneous urticaria: results of a\u00a0pilot study. Br J Dermatol 178(2):561\u2013562. https:\/\/doi.org\/10.1111\/bjd.15705","journal-title":"Br J Dermatol"},{"key":"1428_CR35","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3389\/fimmu.2019.00546","volume":"10","author":"H Bonnekoh","year":"2019","unstructured":"Bonnekoh\u00a0H, Scheffel\u00a0J, Wu\u00a0J, Hoffmann\u00a0S, Maurer\u00a0M, Krause\u00a0K (2019) Skin and systemic inflammation in Schnitzler\u2019s syndrome are associated with neutrophil extracellular trap formation. Front Immunol 10:546. https:\/\/doi.org\/10.3389\/fimmu.2019.00546","journal-title":"Front Immunol"},{"key":"1428_CR36","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/rheumatology\/kep222","volume":"48","author":"C Pizzirani","year":"2009","unstructured":"Pizzirani\u00a0C, Falzoni\u00a0S, Govoni\u00a0M et\u00a0al (2009) Dysfunctional inflammasome in Schnitzler\u2019s syndrome. Rheumatology 48:1304\u20131308. https:\/\/doi.org\/10.1093\/rheumatology\/kep222","journal-title":"Rheumatology"},{"issue":"6","key":"1428_CR37","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.jaci.2019.12.909","volume":"145","author":"K Krause","year":"2020","unstructured":"Krause\u00a0K, Bonnekoh\u00a0H, Ellrich\u00a0A et al (2020) Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome. J\u00a0Allergy Clin Immunol 145(6):1681\u20131686.e5. https:\/\/doi.org\/10.1016\/j.jaci.2019.12.909","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"1428_CR38","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1398-9995.2012.02843.x","volume":"67","author":"K Krause","year":"2012","unstructured":"Krause\u00a0K, Weller\u00a0K, Stefaniak\u00a0R et al (2012) Efficacy and safety of the interleukin\u20111 antagonist rilonacept in Schnitzler syndrome: an open-label study. Allergy 67(7):943\u2013950. https:\/\/doi.org\/10.1111\/j.1398-9995.2012.02843.x","journal-title":"Allergy"},{"key":"1428_CR39","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1093\/rheumatology\/kem244","volume":"46","author":"HD de Koning","year":"2007","unstructured":"de Koning\u00a0HD, van der Meer\u00a0JW, Simon\u00a0A (2007) Comment on: Schnitzlers syndrome\u2014exacerbation after anti-TNF treatment. Rheumatology 46:1741 (author reply 1741)","journal-title":"Rheumatology"},{"issue":"10","key":"1428_CR40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","volume":"14","author":"E Feist","year":"2018","unstructured":"Feist\u00a0E, Mitrovic\u00a0S, Fautrel\u00a0B (2018) Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease. Nat Rev Rheumatol 14(10):603\u2013618. https:\/\/doi.org\/10.1038\/s41584-018-0081-x","journal-title":"Nat Rev Rheumatol"},{"key":"1428_CR41","doi-asserted-by":"publisher","unstructured":"Kedor\u00a0C, Feist\u00a0E (2017) Adulter Morbus Still \u2013 Neues zur Diagnostik und Therapie \u2013 Adult-Onset Still\u2019s Disease: New Developments in Diagnostics and Treatment. Akt Rheumatol 42:37\u201345. https:\/\/doi.org\/10.1055\/s-0042-118879","DOI":"10.1055\/s-0042-118879"},{"issue":"10","key":"1428_CR42","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1016\/S2665-9913(21)00219-8","volume":"3","author":"D Magliulo","year":"2021","unstructured":"Magliulo\u00a0D, Narayan\u00a0S, Ue\u00a0F, Boulougoura\u00a0A, Badlissi\u00a0F (2021) Adult-onset Still\u2019s disease after mRNA COVID-19 vaccine. Lancet Rheumatol 3(10):e680\u2013e682. https:\/\/doi.org\/10.1016\/S2665-9913(21)00219-8","journal-title":"Lancet Rheumatol"},{"issue":"7","key":"1428_CR43","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s10067-016-3308-8","volume":"35","author":"P Sfriso","year":"2016","unstructured":"Sfriso\u00a0P, Priori\u00a0R, Valesini\u00a0G et al (2016) Adult-onset Still\u2019s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245\u00a0patients. Clin Rheumatol 35(7):1683\u20131689. https:\/\/doi.org\/10.1007\/s10067-016-3308-8","journal-title":"Clin Rheumatol"},{"issue":"7","key":"1428_CR44","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","volume":"13","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin\u00a0M, Jamilloux\u00a0Y, Iwaz\u00a0J, Seve\u00a0P (2014) Adult-onset Still\u2019s disease. Autoimmun Rev 13(7):708\u2013722. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.058","journal-title":"Autoimmun Rev"},{"key":"1428_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10040733","author":"S Tomaras","year":"2021","unstructured":"Tomaras\u00a0S, Goetzke\u00a0CC, Kallinich\u00a0T, Feist\u00a0E (2021) Adult-onset still\u2019s disease: clinical aspects and therapeutic approach. J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/jcm10040733","journal-title":"J Clin Med"},{"issue":"3","key":"1428_CR46","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi\u00a0M, Ohta\u00a0A, Tsunematsu\u00a0T et\u00a0al (1992) Preliminary criteria for classification of adult Still\u2019s disease. J\u00a0Rheumatol 19(3):424\u2013430","journal-title":"J Rheumatol"},{"key":"1428_CR47","doi-asserted-by":"crossref","unstructured":"Vordenb\u00e4umen S, Feist E, Rech J, et\u00a0al. Diagnostik und Therapie des adulten Still-Syndroms (AOSD). AWMF online2022.","DOI":"10.1007\/s00393-022-01277-3"},{"key":"1428_CR48","doi-asserted-by":"publisher","first-page":"1759720X2110595","DOI":"10.1177\/1759720X211059598","volume":"13","author":"C Kedor","year":"2021","unstructured":"Kedor\u00a0C, Tomaras\u00a0S, Baeumer\u00a0D, Feist\u00a0E (2021) Update on the therapy of adult-onset Still\u2019s disease with a\u00a0focus on IL-1-inhibition: a\u00a0systematic review. Ther Adv Musculoskelet Dis 13:1759720X211059598. https:\/\/doi.org\/10.1177\/1759720X211059598","journal-title":"Ther Adv Musculoskelet Dis"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01428-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-023-01428-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01428-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T12:03:56Z","timestamp":1697112236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-023-01428-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1428"],"URL":"https:\/\/doi.org\/10.1007\/s00393-023-01428-0","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,6]]},"assertion":[{"value":"6 September 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>A.\u00a0Pankow:<\/b> A.\u00a0Finanzielle Interessen: Referentent\u00e4tigkeit: Novartis, Sobi.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellt in der Medizinische Klinik mit Schwerpunkt Rheumatologie und klinische Immunologie, Charit\u00e9 Berlin, seit\u00a02\/2021; 1.\u00a0Vorsitzende des Autoinflammation Network e.\u202fV. (ANEV) | Mitgliedschaft: Deutsche Gesellschaft f\u00fcr Rheumatologie (DGRh). <b>E.\u00a0Feist:<\/b> A.\u00a0Finanzielle Interessen: Vortr\u00e4ge f\u00fcr Novartis und Sobi.\u00a0\u2013 Beratert\u00e4tigkeit bei Advisory Boards f\u00fcr Novartis und Sobi.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Rheumatologe, Klinik f\u00fcr Rheumatologie, Helios Fachklinik Vogelsang-Gommern; Chefarzt; Vorstandsmitglied im Bundesverband Deutscher Rheumatologen (BDRh). <b>H.\u00a0Bonnekoh:<\/b> A.\u00a0Finanzielle Interessen: Vortr\u00e4ge und Advisory Boards f\u00fcr AbbVie, Intercept Pharma, Novartis, Sanofi-Aventis und ValenzaBio Inc. Es besteht kein Interessenkonflikt in Bezug auf den vorliegenden Artikel.\u00a0\u2013 Bezahlte Beratungsleistungen, interne Schulungsvortr\u00e4ge, Gehaltsbezug o.\u202f\u00c4.: H.\u00a0Bonnekoh erhielt Honorare f\u00fcr Vortr\u00e4ge und Advisory Boards von AbbVie, Intercept Pharma, Novartis, Sanofi-Aventis und ValenzaBio Inc. Es besteht kein Interessenkonflikt in Bezug auf den vorliegenden Artikel.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte Fach\u00e4rztin f\u00fcr Dermatologie und Venerologie, Institut f\u00fcr Allergieforschung, Charit\u00e9\u00a0\u2013 Universit\u00e4tsmedizin Berlin. <b>A.D.\u00a0Wagner:<\/b> A.\u00a0Finanzielle Interessen: A.D.\u00a0Wagner gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin, Ambulanz f\u00fcr seltene entz\u00fcndliche Systemerkrankungen mit Nierenbeteiligung, Abteilung f\u00fcr Nieren- und Hochdruckerkrankungen, Medizinische Hochschule Hannover. <b>M.\u00a0Krusche:<\/b> A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Novartis, Sobi.\u00a0\u2013 Referentent\u00e4tigkeit: Novartis, Sobi.\u00a0\u2013 Beratert\u00e4tigkeit: Novartis, Sobi.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Rheumatologe, Charit\u00e9 Berlin bis\u00a006\/2021, ab\u00a007\/22 III. Medizinische Klinik und Poliklinik f\u00fcr Nephrologie, Rheumatologie und Endokrinologie, Universit\u00e4tsklinikum Hamburg-Eppendorf | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Rheumatologie (DGRh), Mitglied des Vorstands der DGRh seit 2021.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autorinnen und Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}